151 related articles for article (PubMed ID: 23294503)
1. The fibrillin-1 hypomorphic mgR/mgR murine model of Marfan syndrome shows severe elastolysis in all segments of the aorta.
Schwill S; Seppelt P; Grünhagen J; Ott CE; Jugold M; Ruhparwar A; Robinson PN; Karck M; Kallenbach K
J Vasc Surg; 2013 Jun; 57(6):1628-36, 1636.e1-3. PubMed ID: 23294503
[TBL] [Abstract][Full Text] [Related]
2. Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.
Seppelt PC; Schwill S; Weymann A; Arif R; Weber A; Zaradzki M; Richter K; Ensminger S; Robinson PN; Wagner AH; Karck M; Kallenbach K
PLoS One; 2016; 11(2):e0148012. PubMed ID: 26840980
[TBL] [Abstract][Full Text] [Related]
3. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
[TBL] [Abstract][Full Text] [Related]
4. Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment.
Guo G; Booms P; Halushka M; Dietz HC; Ney A; Stricker S; Hecht J; Mundlos S; Robinson PN
Circulation; 2006 Oct; 114(17):1855-62. PubMed ID: 17030689
[TBL] [Abstract][Full Text] [Related]
5. AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of Marfan syndrome.
Remes A; Arif R; Franz M; Jungmann A; Zaradzki M; Puehler T; Heckmann MB; Frey N; Karck M; Kallenbach K; Hecker M; Müller OJ; Wagner AH
Cardiovasc Res; 2021 Nov; 117(12):2459-2473. PubMed ID: 33471064
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
7. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome.
Bunton TE; Biery NJ; Myers L; Gayraud B; Ramirez F; Dietz HC
Circ Res; 2001 Jan; 88(1):37-43. PubMed ID: 11139471
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
10. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
11. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
[TBL] [Abstract][Full Text] [Related]
12. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
[TBL] [Abstract][Full Text] [Related]
13. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
Nistala H; Lee-Arteaga S; Carta L; Cook JR; Smaldone S; Siciliano G; Rifkin AN; Dietz HC; Rifkin DB; Ramirez F
Hum Mol Genet; 2010 Dec; 19(24):4790-8. PubMed ID: 20871099
[TBL] [Abstract][Full Text] [Related]
15. Aortic Strain Correlates with Elastin Fragmentation in Fibrillin-1 Hypomorphic Mice.
Chen JZ; Sawada H; Moorleghen JJ; Weiland M; Daugherty A; Sheppard MB
Circ Rep; 2019 May; 1(5):199-205. PubMed ID: 31123721
[TBL] [Abstract][Full Text] [Related]
16. Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome.
Marque V; Kieffer P; Gayraud B; Lartaud-Idjouadiene I; Ramirez F; Atkinson J
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1184-9. PubMed ID: 11451749
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1.
Pereira L; Lee SY; Gayraud B; Andrikopoulos K; Shapiro SD; Bunton T; Biery NJ; Dietz HC; Sakai LY; Ramirez F
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3819-23. PubMed ID: 10097121
[TBL] [Abstract][Full Text] [Related]
18. Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome.
Zaradzki M; Mohr F; Lont S; Soethoff J; Remes A; Arif R; Müller OJ; Karck M; Hecker M; Wagner AH
Biochem Pharmacol; 2022 Nov; 205():115280. PubMed ID: 36198355
[TBL] [Abstract][Full Text] [Related]
19. Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome.
Lee JJ; Galatioto J; Rao S; Ramirez F; Costa KD
Ann Biomed Eng; 2016 Oct; 44(10):2994-3006. PubMed ID: 27090893
[TBL] [Abstract][Full Text] [Related]
20. Role of fibrillin-1 in hypertensive and diabetic glomerular disease.
Hartner A; Schaefer L; Porst M; Cordasic N; Gabriel A; Klanke B; Reinhardt DP; Hilgers KF
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1329-36. PubMed ID: 16380460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
